Propiedad y actividad de insiders de Nuvalent, Inc. (NUVL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $123.96 |
| Capitalización | $9.1B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-15 | Flynn James E | D-Return | 650,000 | $80.6M |
| 2026-07-15 | Flynn James E | U-Tender | 5,146 | $638K |
| 2026-07-15 | Flynn James E | D-Return | 3,444 | $427K |
| 2026-07-15 | Flynn James E | D-Return | 2,717,627 | |
| 2026-07-15 | Flynn James E | D-Return | 43,000 | $731K |
| 2026-07-15 | Flynn James E | D-Return | 20,000 | $187K |
| 2026-07-15 | Flynn James E | D-Return | 15,000 | $670K |
| 2026-07-15 | Flynn James E | D-Return | 3,789 | $303K |
| 2026-07-15 | Flynn James E | D-Return | 4,147 | $313K |
| 2026-07-15 | Meyers Michael L. | U-Tender | 5,146 | $638K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.0M | $10.3M | $68.5M | $241.8M | $335.4M | $145.7M | $261.7M |
| Inversiones a Corto | 0 | 0 | $219.6M | $230.4M | $384.5M | $972.6M | $1.11B |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $3.3M | $10.6M | $290.6M | $478.0M | $726.5M | $1.13B | $1.39B |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $3.3M | $10.6M | $293.8M | $482.5M | $732.4M | $1.14B | $1.41B |
| Cuentas por Pagar | $723000 | $1.3M | $2.9M | $7.2M | $9.3M | $5.2M | $30.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $4.4M | $4.4M | $8.8M | $19.5M | $31.8M | $54.0M | $91.2M |
| Deuda a Largo | $2.2M | $2.2M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $20.6M | $42.0M | $8.8M | $19.5M | $31.8M | $72.0M | $164.4M |
| Reservas | -$17.3M | -$31.9M | -$78.2M | -$160.1M | -$286.3M | -$547.1M | -$972.4M |
| Patrimonio Neto | -$17.3M | -$31.3M | $285.0M | $463.0M | $700.6M | $1.07B | $1.25B |
| Deuda Total | $2.2M | $2.2M | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$843000 | -$8.1M | -$288.1M | -$472.2M | -$719.9M | -$1.12B | -$1.37B |
| Capital Circulante | -$1.0M | $6.3M | $281.8M | $458.5M | $694.7M | $1.08B | $1.30B |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 16.14 |
Rentabilidad
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ABVX · ARWR · AXSM · CRSP · CYTK · JAZZ · MRUS
Explorar sector: Healthcare · Biotechnology
Más secciones de NUVL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones